activ
bacteri
core
surveil
abc
establish
part
center
diseas
control
prevent
emerg
infect
program
eip
network
assess
extent
invas
bacteri
infect
public
health
import
abc
distinct
among
surveil
system
larg
populationbas
geograph
divers
catchment
area
activ
laboratorybas
identif
case
ensur
complet
case
captur
detail
collect
epidemiolog
inform
pair
laboratori
isol
infrastructur
allow
indepth
investig
sustain
commit
public
health
academ
clinic
partner
maintain
system
abc
directli
affect
public
health
polici
practic
develop
evalu
vaccin
prevent
strategi
monitor
antimicrobi
drug
resist
respons
public
health
emerg
emerg
infect
ctive
bacteri
core
surveil
abc
program
center
diseas
control
prevent
cdc
emerg
infect
program
eip
network
launch
part
cdc
strategi
address
worldwid
threat
emerg
infecti
diseas
goal
eip
detect
investig
emerg
pathogen
integr
laboratori
scienc
epidemiolog
enhanc
commun
emerg
diseas
strengthen
state
feder
public
health
infrastructur
regard
surveil
prevent
control
program
establish
eip
littl
known
nation
burden
mani
diseas
area
surveil
umbrella
includ
foodborn
diseas
influenzarel
hospit
health
careassoci
infect
invas
bacteri
infect
abc
eip
activ
collabor
cdc
state
local
health
depart
academ
institut
origin
establish
site
california
connecticut
oregon
minnesota
abc
ad
georgia
maryland
new
york
tennesse
colorado
new
mexico
total
site
site
repres
geograph
divers
approxim
racial
composit
us
popul
current
popul
surveil
rang
million
us
popul
depend
pathogen
abc
provid
populationbas
surveil
select
caus
invas
bacteri
infect
commun
primarili
manifest
bloodstream
infect
mening
incept
continu
today
includ
surveil
invas
infect
caus
group
streptococcu
ga
haemophilu
influenza
neisseria
meningitidi
group
b
streptococcu
gb
streptococcu
pneumonia
surveil
invas
methicillinresist
staphylococcu
aureu
mrsa
long
recogn
signific
nosocomi
pathogen
ad
surveil
emerg
substanti
caus
invas
infect
commun
rise
rate
pertussi
http
wwwcdcgovpertussissurvreportinghtml
legionellosi
led
addit
special
surveil
diseas
abc
invas
pneumococc
diseas
ipd
provid
exampl
power
larg
sustain
populationbas
surveil
system
evalu
public
health
intervent
provid
feedback
addit
prevent
measur
although
pneumonia
major
caus
invas
infect
eg
bloodstream
infect
mening
unit
state
worldwid
ipd
twenti
year
activ
bacteri
core
surveil
report
state
late
new
vaccin
develop
system
need
determin
baselin
rate
ipd
evalu
vaccin
effect
monitor
circul
serotyp
establish
abc
fill
void
track
diseas
burden
ipd
major
caus
invas
bacteri
diseas
unit
state
abc
detect
larg
reduct
ipd
detect
among
children
year
age
vaccin
pneumococc
conjug
vaccin
recommend
among
adult
benefit
herd
protect
abc
also
recogn
increas
ipd
rate
caus
pneumonia
serotyp
absent
inform
result
acceler
approv
pneumococc
vaccin
result
reduct
ipd
infect
captur
abc
report
cdc
even
infect
includ
cdc
nation
notifi
diseas
surveil
system
case
count
may
underestim
reli
report
laboratori
clinician
wherea
abc
tri
activ
identifi
case
within
surveil
area
addit
epidemiolog
data
collect
health
depart
often
incomplet
limit
resourc
inflex
system
captur
variabl
interest
unlik
nation
notifi
diseas
surveil
system
abc
also
collect
isol
serotyp
test
antimicrobi
drug
suscept
attribut
enabl
abc
fulfil
critic
object
determin
incid
epidemiolog
characterist
invas
diseas
surveil
determin
molecular
epidemiolog
pattern
microbiolog
characterist
invas
infect
routin
surveil
case
invas
bacteri
diseas
defin
isol
h
influenza
n
meningitidi
ga
gb
pneumonia
mrsa
normal
steril
bodi
site
eg
blood
joint
pleural
cerebrospin
fluid
resid
surveil
area
addit
case
includ
ill
person
ga
isol
wound
tissu
presenc
necrot
fasciiti
streptococc
toxic
shock
syndrom
case
gb
mother
also
includ
gb
isol
placenta
amniot
fluid
event
fetal
death
abc
approach
surveil
distinct
activ
laboratori
base
popul
base
goal
detect
laboratoryconfirm
case
activ
contact
clinic
laboratori
routin
process
specimen
resid
surveil
area
audit
perform
regularli
ensur
case
captur
effort
site
make
abc
pathogen
report
state
public
health
agenc
facilit
particip
almost
laboratori
serv
surveil
popul
popul
surveil
welldefin
us
censu
data
use
calcul
diseas
incid
rate
within
abc
popul
larg
popul
base
cdc
use
abc
data
estim
nation
diseas
burden
adjust
race
age
distribut
unit
state
medic
record
review
use
collect
demograph
clinic
cours
outcom
infect
type
underli
condit
vaccin
histori
casepati
patient
isol
first
posit
cultur
collect
sinc
except
mrsa
conveni
sampl
isol
collect
sinc
isol
collect
elig
patient
isol
undergo
serolog
molecular
type
standard
antimicrobi
drug
suscept
test
cdc
refer
laboratori
collect
pneumonia
ga
gb
n
meningitid
h
influenza
isol
access
abc
partner
extern
research
request
http
wwwcdcgovabcspathogensisolatebankindex
html
abc
mrsa
isol
deposit
network
antimicrobi
resist
staphylococcu
aureu
repositori
sponsor
nation
institut
allergi
infecti
diseas
nation
institut
health
http
wwwniaidnihgovlabsandresourcesresourc
dmidnarsapagesdefaultaspx
abc
infrastructur
also
use
conduct
surveil
bacteri
diseas
provid
foundat
epidemiolog
investig
exampl
includ
special
surveil
pertussi
legionellosi
casecontrol
studi
assess
vaccin
effect
cohort
studi
assess
uptak
effect
public
health
intervent
larg
repres
catchment
area
laboratorylink
populationbas
epidemiolog
data
result
abc
use
develop
prelicensur
evalu
multipl
vaccin
licensur
abc
data
use
formul
polici
recommend
determin
realworld
impact
vaccin
tabl
mention
earlier
abc
close
track
declin
ipd
children
introduct
figur
perhap
surpris
find
would
possibl
without
larg
abc
catchment
area
includ
surveil
among
age
group
declin
vaccinetyp
ipd
among
adult
particularli
year
age
figur
abc
also
identifi
increas
incid
ipd
serotyp
found
particularli
serotyp
find
contribut
acceler
approv
includ
serotyp
recommend
use
children
year
age
rate
ipd
declin
sinc
introduct
figur
ageand
serogroupspecif
abc
data
highlight
increas
risk
vaccineprevent
meningococc
diseas
among
colleg
student
adolesc
young
adult
find
contribut
advisori
committe
immun
practic
polici
recommend
routin
use
meningococc
conjug
vaccin
person
year
age
subsequ
recommend
booster
dose
late
adolesc
longstand
surveil
abc
abl
document
persist
declin
invas
h
influenza
infect
among
young
children
introduct
type
b
vaccin
figur
abc
surveil
h
influenza
type
b
hib
diseas
critic
monitor
vaccin
shortag
affect
diseas
rate
avail
epidemiolog
data
link
serotyp
determin
shift
toward
nonhib
diseas
adult
posthib
vaccin
era
recogn
although
trend
data
may
show
indirect
evid
vaccin
effect
proof
effect
requir
formal
epidemiolog
investig
account
factor
may
influenc
declin
diseas
incid
abc
infrastructur
use
conduct
casecontrol
studi
confirm
effect
conjug
meningococc
pneumococc
vaccin
invas
diseas
larg
studi
could
done
integr
network
highlight
effici
gain
maintain
infrastructur
serotyp
serogroup
data
abc
pathogen
also
use
help
formul
vaccin
evalu
potenti
effect
vaccin
current
develop
includ
product
target
ga
gb
aureu
serogroup
b
meningococc
diseas
abc
data
use
predict
effect
unit
state
ga
vaccin
ga
vaccin
develop
gb
diseas
burden
serotyp
data
gather
abc
use
inform
develop
trival
gb
vaccin
phase
ii
trial
abc
data
use
determin
popul
group
would
best
candid
receipt
aureu
vaccin
prevent
invas
mrsa
diseas
evalu
potenti
effect
serogroup
b
meningococc
vaccin
diseas
burden
unit
state
abc
precursor
surveil
system
gb
use
defin
need
guidelin
provid
antimicrobi
drug
pregnant
women
deliveri
prevent
earlyonset
gb
newborn
guidelin
publish
without
evid
strategi
better
guidelin
recommend
health
care
provid
could
use
either
screen
riskbas
approach
decid
women
receiv
prophylaxi
deliveri
abcsbas
cohort
studi
sampl
popul
liveborn
infant
site
demonstr
valu
screen
riskbas
approach
specif
univers
prenat
screen
pregnant
women
vaginalrect
colon
gb
provid
antimicrobi
drug
deliveri
colon
effect
prevent
earli
onset
gb
provid
prophylaxi
pregnant
women
basi
certain
risk
factor
find
led
issuanc
new
guidelin
revis
guidelin
result
reduct
diseas
sinc
earli
abc
document
declin
incid
earlyonset
gb
infect
prevent
estim
case
earlyonset
gb
infect
figur
guidelin
prevent
invas
ga
infect
also
inform
abc
surveil
special
studi
abc
studi
found
increas
risk
sever
ga
infect
among
household
contact
index
patient
data
coupl
data
collect
routin
surveil
frequenc
ga
infect
postpartum
women
postsurg
patient
provid
foundat
develop
cdc
polici
guidanc
household
health
care
set
abc
surveil
data
risk
ga
infect
among
longterm
care
facil
patient
also
help
inform
prevent
control
strategi
set
first
nationwid
estim
burden
invas
mrsa
deriv
abc
case
death
attribut
invas
mrsa
infect
health
careassociatedeith
hospitalonset
cultur
obtain
day
admiss
health
careassoci
communityonset
cultur
obtain
outpati
within
calendar
day
admiss
patient
health
careassoci
risk
factor
includ
presenc
central
venou
cathet
within
day
mrsa
cultur
histori
surgeri
hospit
dialysi
resid
longterm
care
facil
month
preced
cultur
date
promin
health
careassoci
communityonset
infect
newli
brought
light
abc
network
report
led
increas
awar
mrsa
infect
prevent
health
careassoci
mrsa
becam
goal
public
health
agenc
polici
maker
abc
document
declin
hospitalonset
mrsa
declin
health
careassoci
communityonset
mrsa
invas
infect
figur
abcsbas
studi
evalu
risk
factor
health
careassoci
communityonset
mrsa
infect
complet
despit
great
progress
reduc
health
careassoci
mrsa
infect
rate
invas
mrsa
infect
commun
among
person
without
recent
health
care
exposur
communityassoci
infect
remain
larg
unchang
indic
ongo
need
prevent
strategi
outsid
hospit
set
figur
abc
data
show
larg
increas
proport
isol
patient
ipd
resist
penicillin
introduct
analysi
isol
collect
abc
site
found
declin
penicillinnonsuscept
ipd
among
children
year
age
declin
among
adult
year
find
demonstr
effect
routin
use
pneumococc
conjug
vaccin
children
reduc
spread
resist
strain
nation
scale
age
group
howev
abc
isol
patient
ipd
remain
resist
antimicrobi
drug
http
contrast
ipd
ga
infect
remain
sensit
penicillin
ga
isol
collect
monitor
resist
invas
ga
infect
also
macrolid
antimicrobi
drug
abc
data
document
increas
resist
erythromycin
current
macrolid
commonli
use
treat
pharyng
children
allerg
penicillin
http
monitor
antimicrobi
drug
resist
gb
across
larg
geograph
area
critic
antimicrobi
prophylaxi
wide
use
prevent
earlyonset
gb
gb
isol
abc
remain
larg
suscept
firstlin
prophylaxi
treatment
isol
mic
increas
increas
resist
gb
isol
clindamycin
discov
abc
prompt
chang
secondlin
prophylaxi
recommend
intrapartum
women
clindamycin
cefazolin
penicillinallerg
women
low
risk
anaphylaxi
two
report
vancomycinresist
gb
isol
insid
outsid
abc
catchment
area
recent
publish
although
appar
widespread
vancomycin
resist
concern
develop
must
close
monitor
altern
agent
prophylaxi
penicillinallerg
patient
high
risk
anaphylaxi
ciprofloxacinresist
n
meningitidi
identifi
patient
minnesota
within
abc
catchment
area
border
area
north
dakota
abc
site
although
n
meningitidi
isol
routin
collect
serogroup
resist
test
routin
done
previou
evalu
shown
low
level
antimicrobi
drug
resist
potenti
problem
aros
ciprofloxacin
commonli
use
agent
prophylaxi
close
contact
exist
abc
infrastructur
use
test
n
meningitidi
isol
antimicrobi
drug
resist
addit
abc
isol
collect
found
resist
ciprofloxacin
provid
reassur
chemoprophylaxi
polici
recommend
continu
sound
emerg
infecti
diseas
wwwcdcgoveid
vol
septemb
one
key
attribut
abc
eip
activ
flexibl
respond
public
health
emerg
anthrax
attack
abc
infrastructur
use
establish
test
sensit
time
system
identifi
inhal
anthrax
connecticut
discoveri
sever
acut
respiratori
syndrom
eip
infrastructur
assist
surveil
activ
investig
suspect
case
influenza
pandem
earli
recognit
ipd
among
pandem
influenza
patient
colorado
abc
site
led
increas
emphasi
pneumococc
diseas
prevent
strategi
tennesse
abc
site
help
tennesse
depart
health
investig
recent
outbreak
fungal
mening
abc
also
use
surveil
platform
emerg
infect
includ
pertussi
legionellosi
sinc
number
report
pertussi
case
gradual
increas
case
report
repres
largest
number
case
sinc
figur
http
wwwcdcgovpertussisdownload
ageadjust
incid
legionellosi
almost
tripl
case
per
person
sinc
enhanc
pertussi
surveil
conduct
site
legionellosi
surveil
site
addit
enhanc
surveil
studi
estim
effect
matern
vaccin
prevent
infant
pertussi
way
goal
abc
share
method
experi
domest
intern
partner
addit
provid
materi
method
result
websit
http
wwwcdcgovabcsindexhtml
outreach
partner
provid
multipl
nation
intern
confer
abc
close
collabor
south
africa
nation
institut
communic
diseas
establish
similar
surveil
system
countri
share
lesson
learn
epidemiolog
find
http
wwwnicdacza
pagehomepag
abc
also
use
standard
evalu
valid
less
expens
method
track
antimicrobi
drug
suscept
measur
vaccin
effectivenessmethod
use
set
fewer
resourc
abc
began
case
identifi
review
paper
laboratori
log
sheet
comput
printout
case
report
form
abstract
paper
record
increas
avail
electron
laboratori
medic
record
may
improv
timeli
complet
accuraci
report
ensur
case
appropri
captur
requir
understand
laboratori
inform
system
code
period
review
data
import
extract
inform
transfer
usabl
format
remain
challeng
except
surveil
pertussi
legionellosi
current
abc
case
definit
includ
cultureproven
diseas
although
cultur
remain
standard
diagnos
invas
infect
use
cultureindepend
diagnost
test
probabl
increas
valid
cultureindepend
diagnost
remain
major
consider
determin
whether
cultureindepend
test
ad
abc
case
definit
grow
field
microbi
human
genom
provid
abc
potenti
new
role
increas
understand
diseas
transmiss
pathogenesi
abc
uniqu
pois
evalu
relationship
human
pathogen
genet
variat
infecti
diseas
given
surveil
popul
base
bacteri
isol
collect
studi
current
way
use
wholegenom
sequenc
compar
isol
patient
ga
necrot
fasciiti
streptococc
toxic
shock
syndrom
isol
person
isol
bacteremia
anoth
studi
plan
examin
potenti
differ
host
genom
factor
abc
also
valid
use
wholegenom
sequenc
outbreak
caus
n
meningitidi
unit
state
lead
caus
ill
death
chronic
diseas
better
understand
associ
interact
chronic
diseas
invas
bacteri
infect
need
better
understand
pathophysiolog
potenti
intervent
prognos
invas
bacteri
infect
abc
surveil
data
coupl
data
sourc
use
analyz
influenc
chronic
diseas
ipd
h
influenza
infect
adult
effort
analyz
effect
obes
diabet
incid
sever
abc
pathogen
way
major
goal
abc
assess
public
health
dispar
promot
health
equiti
across
popul
group
abc
document
differ
rate
diseas
across
person
differ
race
invas
gb
http
wwwcdcgovabcsreportsfindingssurvreport
pneumococc
mrsa
http
www
infect
common
among
black
white
person
howev
racial
differ
one
measur
dispar
categor
person
race
becom
increasingli
difficult
unit
state
becom
multiraci
abc
analys
incorpor
censu
tract
data
determin
associ
arealevel
poverti
diseas
incid
abc
start
incorpor
censu
tract
inform
routin
surveil
abc
distinct
among
public
health
surveil
system
design
captur
nearli
case
cultureconfirm
invas
bacteri
diseas
larg
welldefin
geograph
divers
area
unit
state
comprehens
data
enabl
accur
estim
nation
diseas
burden
sever
bacteri
infect
surveil
collect
isol
conjunct
epidemiolog
data
contribut
microbiolog
molecular
character
pathogen
play
part
develop
vaccin
monitor
antimicrobi
drug
resist
although
surveil
system
alon
provid
power
data
inform
public
health
action
larg
abc
infrastructur
provid
effici
effect
platform
engag
special
investig
would
otherwis
requir
addit
resourc
infrastructur
also
provid
flexibl
need
respond
emerg
serv
surveil
platform
emerg
pathogen
perhap
greatest
strength
abc
reason
success
commit
genial
longlast
collabor
among
local
state
feder
agenc
academ
institut
clinic
laboratori
although
abc
address
mani
question
public
health
signific
directli
affect
public
health
polici
practic
mani
question
still
remain
tabl
maintain
abil
abc
answer
question
high
import
network
must
continu
embrac
adapt
chang
public
health
laboratori
inform
technolog
medic
landscap
